[1] Zou XN, Zhao Ping. Analysis of cancer situation in China in the past 70 years. Chinese Journal of clinical oncology and rehabilitation, 2019;10:1153-61.
[2] Zheng WH, Yang HW. Research progress of chemotherapy-induced neuropathic pain. Cancer prevention and treatment research, 2010;9:1081-3.
[3] Fallon MT. Neuropathic pain in cancer. Br J Anaesth. 2013; 1:105-11.
[4] Pignata S, De Placido S, Biamonte R, Scambia G, Di Vagno G, Colucci G, et al. Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. BMC Cancer. 2006;6:5.
[5] Kerckhove N, Collin A, Condé S, Chaleteix C, Pezet D, Balayssac D. Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review. Front Pharmacol. 2017;8:86.
[6] Flatters SJL, Dougherty PM, Colvin LA. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. Br J Anaesth. 2017;4:737-49.
[7] Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004;22:23-30.
[8] Sakurai M, Egashira N, Kawashiri T, Yano T, Ikesue H, Oishi R. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia. Pain. 2009;1:165-74.
[9] Cao Peng, Li Songlin, Huo Jiege. Treatment of oxaliplatin related peripheral neuropathy by blood arthralgia. Chinese Journal of basic medicine of traditional Chinese medicine, 2013;4: 430-1.
[10] Cao Peng, Huo JG. Treatment of chemotherapy-related peripheral neuropathy from blood arthralgia. Guangming traditional Chinese medicine, 2013;1:12-3, 15.
[11] Jiang Mei, Chen Lu, Ke XB. Discussion on the thinking of differentiation and treatment of oxaliplatin in neurologic differentiation of blood arthralgia theory. Chinese Journal of traditional Chinese medicine, 2012;9: 2135-7.
[12] Tian Jun, Yao XQ, Wu XY, Chen Che, Zhou Liang, Xu Zhe, et al. Systematic review and meta-analysis of Huangqi Guizhi Wuwu Decoction in the prevention and treatment of oxaliplatin peripheral nerve toxicity. Chinese Journal of experimental prescription, 2013;22:325-30.
[13] Chen Shanshan. Systematic review and meta-analysis of Huangqi Guizhi Wuwu Decoction in the prevention and treatment of oxaliplatin induced peripheral neurotoxicity [D]. Nanjing University of traditional Chinese medicine, 2018.
[14] Ma Jun. a multicenter, randomized, double-blind, controlled clinical study on the prevention and treatment of Oxaliplatin Neurotoxicity by modified Huangqi Guizhi Wuwu formula granules [D]. Nanjing University of traditional Chinese medicine, 2019.
[15] Huang ZB, Huang ZM, Chen GQ, Tao Yu, Huang ZY, Jin HL, et al. Clinical study on the prevention and treatment of oxaliplatin peripheral neurotoxicity with Huangqi Guizhi Wuwu Decoction. Shanghai Journal of traditional Chinese medicine, 2010;5:40-2.
[16] Nishimoto S, Kusakabe M, Nishida E. Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development. EMBO Rep. 2005; 6:1064-9.
[17] Yamamoto K, Chiba N, Chiba T, Kambe T, Abe K, Kawakami K, et al. Transient receptor potential ankyrin 1 that is induced in dorsal root ganglion neurons contributes to acute cold hypersensitivity after oxaliplatin administration. Mol Pain. 2015; 11:69.
[18] Huo JG, Hu Ying, Yang Jie, Cai XT, Hu CP, Wang XN, et al. Effect of Huangqi Guizhi Wuwu Decoction on peripheral nerve injury induced by chemotherapy. Journal of traditional Chinese medicine, 2012;23:2031-4.
[19] Xiao WH, Zheng H, Bennett GJ. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience. 2012; 203:194–206.
[20] Ling B, Authier N, Balayssac D, Eschalier A, Coudore F. Behavioral and pharmacological description of oxaliplatin induced painful neuropathy in rat. Pain, 2007; 128:225–34.
[21] Ashlin TG, Buckley ML, Salter RC, Johnson JL, Kwan AP, Ramji DP. The anti-atherogenic cytokine interleukin-33 inhibits the expression of a disintegrin and metalloproteinase with thrombospondin motifs-1, -4 and -5 in human macrophages: Requirement of extracellular signal-regulated kinase, c-Jun N-terminal kinase and phosphoinositide 3-kinase signaling pathways. Int J Biochem Cell Biol. 2014;100:113-23.
[22] Livni L, Lees JG, Barkl-Luke ME, Goldstein D, Moalem-Taylor G. Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture. Neurosci Lett. 2019;694:14-9.
[23] Kanat O, Ertas H, Caner B. Platinum-induced neurotoxicity: A review of possible mechanisms. World J Clin Oncol. 2017;4:329-35.
[24] Screnci D, McKeage MJ, Galettis P, Hambley TW, Palmer BD, Baguley BC. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. Br J Cancer. 2000;4:966-72.
[25] Ramesh G, MacLean AG, Philipp MT. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013; 2013:480739.
[26] Liang F, Liu M, Fu X, Zhou X, Chen P, Han F. Dexmedetomidine attenuates neuropathic pain in chronic constriction injury by suppressing NR2B, NF-κB, and iNOS activation. Saudi Pharm J. 2017;4:649-54.
[27] Huh Y, Ji RR, Chen G. Neuroinflammation, Bone Marrow Stem Cells, and Chronic Pain. Front Immunol. 2017; 8:1014.
[28] Chen X, Wu S, Chen C, Xie B, Fang Z, Hu W, et al. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury. J Neuroinflammation. 2017;1:143.
[29] Chen T, Cao L, Dong W, Luo P, Liu W, Qu Y, et al. Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK/ERK pathway. Neurochem Res. 2012;5:983-90.
[30] Tao L, Li D, Liu H, Jiang F, Xu Y, Cao Y, et al. Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway. Brain Res Bull. 2018;140:154-161.
[31] Neurath MF, Pettersson S, Meyer zum Büschenfelde KH, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996;9:998-1004.
[32] Sandireddy R, Yerra VG, Areti A, Komirishetty P, Kumar A. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int J Endocrinol. 2014;2014:674987.
[33] Ma J, Shi M, Zhang X, Liu X, Chen J, Zhang R, et al. GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats. Int J Mol Med. 2018;5:2977-85.